Further we validated this result in another dataset GSE10971 termed as ‘validation dataset’ and also found increased expression of UBE2Q1 in tumor samples of high grade serous ovarian cancer patients (n = 11) compared to non-malignant fallopian tube epithelium tissues (n = 24) (Fig. 4b). The gene discussed is UBE2Q1; the disease is ovarian serous adenocarcinoma.